Global and Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size, Status and Forecast 2023-2027

Report ID: 1015078 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Oral
        1.2.3 Subcutaneous Injection
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Perspective (2016-2027)
    2.2 Hereditary Transthyretin Amyloidosis (HATTR) Growth Trends by Regions
        2.2.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Share by Regions (2016-2021)
        2.2.3 Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Regions (2022-2027)
    2.3 Hereditary Transthyretin Amyloidosis (HATTR) Industry Dynamic
        2.3.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Trends
        2.3.2 Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
        2.3.3 Hereditary Transthyretin Amyloidosis (HATTR) Market Challenges
        2.3.4 Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Revenue
        3.1.1 Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Revenue (2016-2021)
        3.1.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Players (2016-2021)
    3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Hereditary Transthyretin Amyloidosis (HATTR) Revenue
    3.4 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Concentration Ratio
        3.4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2020
    3.5 Hereditary Transthyretin Amyloidosis (HATTR) Key Players Head office and Area Served
    3.6 Key Players Hereditary Transthyretin Amyloidosis (HATTR) Product Solution and Service
    3.7 Date of Enter into Hereditary Transthyretin Amyloidosis (HATTR) Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Hereditary Transthyretin Amyloidosis (HATTR) Breakdown Data by Type
    4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Type (2016-2021)
    4.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Type (2022-2027)

5 Hereditary Transthyretin Amyloidosis (HATTR) Breakdown Data by Application
    5.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Application (2016-2021)
    5.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2016-2027)
    6.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
        6.2.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021)
        6.2.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027)
        6.2.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2027)
    6.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
        6.3.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021)
        6.3.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027)
        6.3.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2027)
    6.4 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
        6.4.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021)
        6.4.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2016-2027)
    7.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
        7.2.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021)
        7.2.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027)
        7.2.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2027)
    7.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
        7.3.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021)
        7.3.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027)
        7.3.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2027)
    7.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
        7.4.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021)
        7.4.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2016-2027)
    8.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
        8.2.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2027)
    8.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
        8.3.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2027)
    8.4 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region
        8.4.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2016-2027)
    9.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
        9.2.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021)
        9.2.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027)
        9.2.3 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2027)
    9.3 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
        9.3.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021)
        9.3.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027)
        9.3.3 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2027)
    9.4 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
        9.4.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021)
        9.4.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2016-2027)
    10.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
        10.2.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2027)
    10.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
        10.3.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2027)
    10.4 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
        10.4.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Introduction
        11.1.4 Pfizer Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Alnylam Pharmaceuticals
        11.2.1 Alnylam Pharmaceuticals Company Details
        11.2.2 Alnylam Pharmaceuticals Business Overview
        11.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Introduction
        11.2.4 Alnylam Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
        11.2.5 Alnylam Pharmaceuticals Recent Development
    11.3 Akcea Therapeutics
        11.3.1 Akcea Therapeutics Company Details
        11.3.2 Akcea Therapeutics Business Overview
        11.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Introduction
        11.3.4 Akcea Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
        11.3.5 Akcea Therapeutics Recent Development
    11.4 Prothena
        11.4.1 Prothena Company Details
        11.4.2 Prothena Business Overview
        11.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Introduction
        11.4.4 Prothena Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
        11.4.5 Prothena Recent Development
    11.5 Lonis Pharmaceuticals
        11.5.1 Lonis Pharmaceuticals Company Details
        11.5.2 Lonis Pharmaceuticals Business Overview
        11.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Introduction
        11.5.4 Lonis Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
        11.5.5 Lonis Pharmaceuticals Recent Development
    11.6 Eidos Therapeutics
        11.6.1 Eidos Therapeutics Company Details
        11.6.2 Eidos Therapeutics Business Overview
        11.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Introduction
        11.6.4 Eidos Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
        11.6.5 Eidos Therapeutics Recent Development
    11.7 Corino Therapeutics Inc
        11.7.1 Corino Therapeutics Inc Company Details
        11.7.2 Corino Therapeutics Inc Business Overview
        11.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Introduction
        11.7.4 Corino Therapeutics Inc Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
        11.7.5 Corino Therapeutics Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Oral
    Table 3. Key Players of Subcutaneous Injection
    Table 4. Key Players of Others
    Table 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Regions (2016-2021)
    Table 9. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Regions (2022-2027)
    Table 11. Hereditary Transthyretin Amyloidosis (HATTR) Market Trends
    Table 12. Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
    Table 13. Hereditary Transthyretin Amyloidosis (HATTR) Market Challenges
    Table 14. Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints
    Table 15. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Players (2016-2021)
    Table 17. Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Transthyretin Amyloidosis (HATTR) as of 2020)
    Table 18. Ranking of Global Top Hereditary Transthyretin Amyloidosis (HATTR) Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Hereditary Transthyretin Amyloidosis (HATTR) Product Solution and Service
    Table 22. Date of Enter into Hereditary Transthyretin Amyloidosis (HATTR) Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2016-2021)
    Table 26. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Application (2016-2021)
    Table 30. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Pfizer Company Details
    Table 63. Pfizer Business Overview
    Table 64. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product
    Table 65. Pfizer Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
    Table 66. Pfizer Recent Development
    Table 67. Alnylam Pharmaceuticals Company Details
    Table 68. Alnylam Pharmaceuticals Business Overview
    Table 69. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product
    Table 70. Alnylam Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
    Table 71. Alnylam Pharmaceuticals Recent Development
    Table 72. Akcea Therapeutics Company Details
    Table 73. Akcea Therapeutics Business Overview
    Table 74. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product
    Table 75. Akcea Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
    Table 76. Akcea Therapeutics Recent Development
    Table 77. Prothena Company Details
    Table 78. Prothena Business Overview
    Table 79. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product
    Table 80. Prothena Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
    Table 81. Prothena Recent Development
    Table 82. Lonis Pharmaceuticals Company Details
    Table 83. Lonis Pharmaceuticals Business Overview
    Table 84. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product
    Table 85. Lonis Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
    Table 86. Lonis Pharmaceuticals Recent Development
    Table 87. Eidos Therapeutics Company Details
    Table 88. Eidos Therapeutics Business Overview
    Table 89. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product
    Table 90. Eidos Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
    Table 91. Eidos Therapeutics Recent Development
    Table 92. Corino Therapeutics Inc Company Details
    Table 93. Corino Therapeutics Inc Business Overview
    Table 94. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product
    Table 95. Corino Therapeutics Inc Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
    Table 96. Corino Therapeutics Inc Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type: 2020 VS 2027
    Figure 2. Oral Features
    Figure 3. Subcutaneous Injection Features
    Figure 4. Others Features
    Figure 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application: 2020 VS 2027
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Others Case Studies
    Figure 9. Hereditary Transthyretin Amyloidosis (HATTR) Report Years Considered
    Figure 10. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Regions: 2020 VS 2027
    Figure 13. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Regions (2022-2027)
    Figure 14. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Players in 2020
    Figure 15. Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Transthyretin Amyloidosis (HATTR) as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2020
    Figure 17. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2016-2021)
    Figure 18. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2022-2027)
    Figure 19. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2016-2027)
    Figure 21. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2016-2027)
    Figure 22. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2016-2027)
    Figure 23. United States Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2016-2027)
    Figure 27. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2016-2027)
    Figure 28. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2016-2027)
    Figure 29. Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region (2016-2027)
    Figure 39. China Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2016-2027)
    Figure 47. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2016-2027)
    Figure 48. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2016-2027)
    Figure 49. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2016-2027)
    Figure 55. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Pfizer Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
    Figure 59. Alnylam Pharmaceuticals Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
    Figure 60. Akcea Therapeutics Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
    Figure 61. Prothena Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
    Figure 62. Lonis Pharmaceuticals Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
    Figure 63. Eidos Therapeutics Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
    Figure 64. Corino Therapeutics Inc Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Alnylam Pharmaceuticals
Akcea Therapeutics
Prothena
Lonis Pharmaceuticals
Eidos Therapeutics
Corino Therapeutics Inc
Frequently Asked Questions
Hereditary Transthyretin Amyloidosis (HATTR) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hereditary Transthyretin Amyloidosis (HATTR) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hereditary Transthyretin Amyloidosis (HATTR) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports